Evidence map›Paper›PMID 29370821›Full record

ArticleOrphanet journal of rare diseases2018

PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases.

Angela Adler, Pia Kirchmeier, Julian Reinhard, Barbara Brauner, Irmtraud Dunger, Gisela Fobo, Goar Frishman, Corinna Montrone, H-Werner Mewes, Matthias Arnold and 1 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. CancerLivER: a database of liver cancer gene expression resources and biomarkers.Database : the journal of biological databases and curation · 2020
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Angela AdlerTechnische Universität München, Chair of Genome Oriented Bioinformatics, Center of Life and Food Science, D-85350, Freising-Weihenstephan, Germany.
Pia KirchmeierInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Julian ReinhardInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Barbara BraunerInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Irmtraud DungerInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Gisela FoboInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Goar FrishmanInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Corinna MontroneInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
H-Werner MewesInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Matthias ArnoldInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany.
Andreas RueppInstitute for Bioinformatics and Systems Biology (IBIS), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), D-85764, Neuherberg, Germany. andreas.ruepp@helmholtz-muenchen.de.ORCID 0000-0003-1705-3515
Helmholtz Zentrum München · DETechnical University of Munich · DE

Funding

Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type DementiasRF1AG051550 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KLING, MITCHEL ALLAN · 2015 to 2016
$6.3M
Metabolic Networks and Pathways in Alzheimer's DiseaseR01AG046171 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F · 2014 to 2017
$4.4M
Metabolomic Signatures Predictive of Outcomes to Treatments for Major DepressionR01MH108348 · NIMH · DUKE UNIVERSITY · PI DUNLOP, BOADIE W, KADDURAH-DAOUK, RIMA F · 2016 to 2019
$2.7M
National Institute on Aging (US) R01AG046171NIA NIH HHS R01 AG046171NIA NIH HHS RF1 AG051550NIA NIH HHS RF1AG051550NIMH NIH HHS R01 MH108348NIMH NIH HHS R01MH108348Qatar National Research Fund NPRP8-061-3-011
6 · The paper itself

Abstract

backgroundThoroughly annotated data resources are a key requirement in phenotype dependent analysis and diagnosis of diseases in the area of precision medicine. Recent work has shown that curation and systematic annotation of human phenome data can significantly improve the quality and selectivity for the interpretation of inherited diseases. We have therefore developed PhenoDis, a comprehensive, manually annotated database providing symptomatic, genetic and imprinting information about rare cardiac diseases.

resultsPhenoDis includes 214 rare cardiac diseases from Orphanet and 94 more from OMIM. For phenotypic characterization of the diseases, we performed manual annotation of diseases with articles from the biomedical literature. Detailed description of disease symptoms required the use of 2247 different terms from the Human Phenotype Ontology (HPO). Diseases listed in PhenoDis frequently cover a broad spectrum of symptoms with 28% from the branch of 'cardiovascular abnormality' and others from areas such as neurological (11.5%) and metabolism (6%). We collected extensive information on the frequency of symptoms in respective diseases as well as on disease-associated genes and imprinting data. The analysis of the abundance of symptoms in patient studies revealed that most of the annotated symptoms (71%) are found in less than half of the patients of a particular disease. Comprehensive and systematic characterization of symptoms including their frequency is a pivotal prerequisite for computer based prediction of diseases and disease causing genetic variants. To this end, PhenoDis provides in-depth annotation for a complete group of rare diseases, including information on pathogenic and likely pathogenic genetic variants for 206 diseases as listed in ClinVar. We integrated all results in an online database ( http://mips.helmholtz-muenchen.de/phenodis/ ) with multiple search options and provide the complete dataset for download.

conclusionPhenoDis provides a comprehensive set of manually annotated rare cardiac diseases that enables computational approaches for disease prediction via decision support systems and phenotype-driven strategies for the identification of disease causing genes.

Indexed as

Computational BiologyDatabases, GeneticGenetic VariationGenomicsHeart DiseasesHumansPhenotypePrecision MedicineRare DiseasesBioinformaticsDecision support systemsGenetic disordersGenotypeHeartMedical geneticsPersonalized medicinePhenotypePrecision medicineRare cardiac diseases

Identifiers

PMID29370821
PMCPMC5785853
OpenAlexW2796602283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.